A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/16510744

N. Engl. J. Med. 2006 Mar 2 354 9 899-910

Download in:

View as

Triples

General Info

PMID
16510744